MICROBIAL SPECTRUM AND OUTCOMES OF ENDOPHTHALMITIS AFTER INTRAVITREAL INJECTION VERSUS PARS PLANA VITRECTOMY

Retina. 2016 Feb;36(2):351-9. doi: 10.1097/IAE.0000000000000694.

Abstract

Purpose: To compare infectious organisms and visual outcomes of endophthalmitis after intravitreal injection (IVI) with endophthalmitis after pars plana vitrectomy (PPV).

Methods: Retrospective, comparative, consecutive case series of patients diagnosed with presumed infectious endophthalmitis after IVI of an anti-vascular endothelial growth factor medication or PPV between January 1, 2009, and October 1, 2012, from one center. Main outcome measures were infectious organism and final visual acuity.

Results: Forty-four cases of presumed infectious endophthalmitis (17 culture positive) occurred after IVI and 19 cases (9 culture positive) occurred after PPV. Of note, 56.3% of culture-positive IVI cases were due to bacteria associated with oral flora, primarily Streptococcus species, compared with none in the PPV group (P = 0.01). There was a trend approaching significance for IVI patients to have lost ≥3 lines of visual acuity compared with PPV patients at final follow-up (P = 0.07). Within the IVI group, patients were more likely to have lost ≥6 lines of visual acuity at final follow-up when endophthalmitis was due to an organism associated with oral flora (P = 0.007).

Conclusion: Endophthalmitis after IVI has a higher likelihood of being due to oral flora compared with endophthalmitis after PPV. Among IVI patients, worse visual outcomes occurred when endophthalmitis was due to oral flora.

Publication types

  • Comparative Study
  • Observational Study

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Amikacin / therapeutic use
  • Angiogenesis Inhibitors / administration & dosage
  • Anti-Bacterial Agents / therapeutic use
  • Bacteria / isolation & purification*
  • Ceftazidime / therapeutic use
  • Drug Combinations
  • Drug Substitution
  • Endophthalmitis / drug therapy
  • Endophthalmitis / microbiology*
  • Endophthalmitis / physiopathology
  • Eye Infections, Bacterial / drug therapy
  • Eye Infections, Bacterial / microbiology*
  • Eye Infections, Bacterial / physiopathology
  • Female
  • Humans
  • Intravitreal Injections*
  • Male
  • Middle Aged
  • Retinal Diseases / therapy*
  • Retrospective Studies
  • Vancomycin / therapeutic use
  • Vascular Endothelial Growth Factor A / antagonists & inhibitors
  • Visual Acuity / physiology*
  • Vitrectomy*
  • Vitreous Body / microbiology

Substances

  • Angiogenesis Inhibitors
  • Anti-Bacterial Agents
  • Drug Combinations
  • VEGFA protein, human
  • Vascular Endothelial Growth Factor A
  • Vancomycin
  • Amikacin
  • Ceftazidime